Historical standard of the first line endometrial cancer therapy was combination of paclitaxel and carboplatin. In more than a half of patients with advanced endometrial cancer receiving this combination. disease progression is observed after 2 years. Use of paclitaxel + carboplatin combination in adjuvant therapy requires search for effective regimens for progression after this syste... https://seriouswatchers.shop/product-category/accessories/